Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
ProceedingsPOSTER VIEWING PRESENTATIONS
Open Access

FINE PARTICULATE MATTER AIR POLLUTION AND ANTINUCLEAR ANTIBODY POSITIVITY: THE ONTARIO HEALTH STUDY

Naizhuo Zhao, Audrey Smargiassi, Hong Chen, May Choi, Marvin Fritzler, Zahi Touma, Philip Awadalla, Antonio Aviña-Zubieta and Sasha Bernatsky
The Journal of Rheumatology May 2025, 52 (Suppl 1) 122; DOI: https://doi.org/10.3899/jrheum.2025-0390.PV075
Naizhuo Zhao
1Research Institute of the McGill University Health Center, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey Smargiassi
2Universite de Montreal, Public Health, Montreal, Canada
3Institut National de Santé Publique du Québec, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Chen
4Institute for Clinical Evaluative Sciences, Toronto, Canada
5Public Health Ontario, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
May Choi
6University of Calgary, Medicine, Calgary, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marvin Fritzler
6University of Calgary, Medicine, Calgary, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zahi Touma
7University of Toronto, Toronto, Canada
8University Health Network, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Awadalla
9Ontario Institute for Cancer Research, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Aviña-Zubieta
10University of British Columbia, Division of Rheumatology, Vancouver, Canada
11Arthritis Research Canada, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sasha Bernatsky
1Research Institute of the McGill University Health Center, Montreal, Canada
12McGill University, Medicine, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Previous
Loading

Abstract

PV075 / #90

Poster Topic: AS10 - Environment and SLE

Background/Purpose Air pollution has been increasingly linked to systemic autoimmune rheumatic diseases (SARDs), but studies of fine particulate matter (PM2.5) and SARD-related serologic biomarkers are limited. In this study, we aimed to assess exposure to ambient PM2.5 and antinuclear antibodies (ANA) in the general population.

Methods We used data and sera from the Ontario Health Study (OHS), which has enrolled 225,000 general population residents of the province of Ontario in Canada. Serum samples from 3548 subjects (collected at enrollment between 2010-2013) were randomly selected from the OHS database/biorepository. Indirect immunofluorescence assay on Hep-2 cells assessed ANA titers (>1:160, >1:320, >1:640, and >1:1280). Annual mean ambient PM2.5 levels for the 5-year period before sera collection were assigned based on subjects’ 6-digit residential postal codes. Our multivariable logistic regression models computed adjusted odds ratios (ORs) for ANA positivity, comparing the highest (fourth) quartile to the lowest (first) quartile in terms of ambient PM2.5. We adjusted for sex, age, race/ethnicity, smoking, and the Rurality Index of Ontario (to characterize subjects’ urban/rural status).

Results Of the 3548 subjects, 2215 (62.4%) were female and 3131 (88.2%) were white. Mean age at serum collection was 54.7 (standard deviation 9.5) years. Multivariate analyses showed females were more likely to be ANA positive than males (Table 1). Comparing the highest vs lowest quartile PM2.5 exposure, the adjusted OR for ANA positivity related to a titer of ≥1:160 was 1.04 (95% CI 0.75-1.44), while for a titer of ≥1:320 the aOR was 1.14 (95% CI 0.77-1.68), for a titer of ≥1:640 the aOR was 1.67 (95% CI 0.99-2.82) and for a titer of ≥1:1280 the aOR was 2.33 (95% CI 1.11-4.91) (Table 2).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Antinuclear positivity in Ontario Health Study general population subjects*

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2.

Adjusted odds, OR (95% confidence interval, CI) for ANA* positivity for ambient fine particulate matter (PM2.5, comparing highest to lowest quartile) adjusting for sex, age, race/ethnicity, smoking, and the Rurality Index of Ontario, RIO

Conclusions Our analyses suggested relationships between PM2.5 exposure and ANA positivity which were most prominent at highest titers. This strengthens the argument for systemic immune system effects of air pollution, which could in turn lead to autoimmune disease.

  • Copyright © 2025 by the Journal of Rheumatology

This is an Open Access article, which permits use, distribution, and reproduction, without modification, provided the original article is correctly cited and is not used for commercial purposes.

Previous
Back to top

In this issue

The Journal of Rheumatology
Vol. 52, Issue Suppl 1
21 May 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FINE PARTICULATE MATTER AIR POLLUTION AND ANTINUCLEAR ANTIBODY POSITIVITY: THE ONTARIO HEALTH STUDY
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
FINE PARTICULATE MATTER AIR POLLUTION AND ANTINUCLEAR ANTIBODY POSITIVITY: THE ONTARIO HEALTH STUDY
Naizhuo Zhao, Audrey Smargiassi, Hong Chen, May Choi, Marvin Fritzler, Zahi Touma, Philip Awadalla, Antonio Aviña-Zubieta, Sasha Bernatsky
The Journal of Rheumatology May 2025, 52 (Suppl 1) 122; DOI: 10.3899/jrheum.2025-0390.PV075

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
FINE PARTICULATE MATTER AIR POLLUTION AND ANTINUCLEAR ANTIBODY POSITIVITY: THE ONTARIO HEALTH STUDY
Naizhuo Zhao, Audrey Smargiassi, Hong Chen, May Choi, Marvin Fritzler, Zahi Touma, Philip Awadalla, Antonio Aviña-Zubieta, Sasha Bernatsky
The Journal of Rheumatology May 2025, 52 (Suppl 1) 122; DOI: 10.3899/jrheum.2025-0390.PV075
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • FACTORS ASSOCIATED WITH EFFICACY OF BELIMUMAB IN DIFFERENT JOINT AND SKIN PHENOTYPES OF SYSTEMIC LUPUS ERYTHEMATOSUS: PRELIMINARY DATA FROM THE MULTICENTER BERLISS-NEJS STUDY
  • LUPUS AND NUTRITION -THE FIRST STEP TO CONTROL YOUR FLARES?
  • RITUXIMAB IN REFRACTORY SLE: 10 YEARS AFTER
Show more POSTER VIEWING PRESENTATIONS

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire